Testing a drug that may help find tumors during brain surgery in children
Original title: Panitumumab-IRDye800 to Detect Pediatric Neoplasms During Neurosurgical Procedures
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
This is an early test in people that looks first at safety.
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
Doctors are testing if a drug called panitumumab-IRDye800 is safe for children during brain surgery.
Who this trial is for. This trial is for children having brain surgery to remove a suspected tumor. It tests a drug called panitumumab-IRDye800, which is meant to help find tumors during that surgery.
Where it stands. The trial is checking how safe this drug is in these children. It has not reported results. The answer is not in yet.
What this means, and what it doesn't
What it could mean: A family whose child fits this picture could ask their care team about it. For now, the trial is looking at safety, not at how well the drug works.
What it doesn't mean: This does not mean the drug is safe or helpful yet. A trial is a test, not a proven treatment. Being in one is not a guarantee of any benefit. It is not a promise of a cure.
Source: ClinicalTrials.gov, September 29, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.